Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AcelRx Pharmaceuticals In...

    NASDAQ: ACRX · Real-Time Price · USD
    0.86
    0.06 (7.50%)
    At close: Jan 09, 2024, 9:00 PM

    AcelRx Pharmaceuticals Statistics

    Share Statistics

    AcelRx Pharmaceuticals has 16.95M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 16.95M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 32

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -1019.14 and the forward PE ratio is null. AcelRx Pharmaceuticals's PEG ratio is 10.19.

    PE Ratio

    n/a
    		 -1019.14

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 16104.23

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 743.27

    P/FCF Ratio

    n/a
    		 -595.94

    PEG Ratio

    n/a
    		 10.19
    Financial Ratio History

    Enterprise Valuation

    AcelRx Pharmaceuticals has an Enterprise Value (EV) of 10.48B.

    EV / Sales

    n/a
    		 16095.44

    EV / EBITDA

    n/a
    		 -620.41

    EV / EBIT

    n/a
    		 -599.02

    EV / FCF

    n/a
    		 -595.62

    Financial Position

    The company has a current ratio of 2.56, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 2.56

    Quick Ratio

    n/a
    		 2.56

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 126.04

    Financial Efficiency

    Return on Equity is -72.93% and Return on Invested Capital is -119.74%.

    Return on Equity

    n/a
    		 -72.93%

    Return on Assets

    n/a
    		 -50.44%

    Return on Invested Capital

    n/a
    		 -119.74%

    Revenue Per Employee

    n/a
    		 $34,263.16

    Profits Per Employee

    n/a
    		 $-541,421.05

    Employee Count

    n/a
    		 19

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -6.72% in the last 52 weeks. The beta is 0.52, so AcelRx Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.52

    52-Week Price Change

    n/a
    		 -6.72%

    50-Day Moving Average

    n/a
    		 0.83

    200-Day Moving Average

    n/a
    		 0.84

    Relative Strength Index (RSI)

    n/a
    		 49.79

    Average Volume (20 Days)

    n/a
    		 138,824

    Income Statement

    In the last 12 months, AcelRx Pharmaceuticals had revenue of 651K and earned -10.29M in profits. Earnings per share was 0.

    Revenue

    n/a
    		 651K

    Gross Profit

    n/a
    		 651K

    Operating Income

    n/a
    		 -16.89M

    Net Income

    n/a
    		 -10.29M

    EBITDA

    n/a
    		 -16.89M

    EBIT

    n/a
    		 -10.42M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 5.72M in cash and 0 in debt, giving a net cash position of 5.72M.

    Cash & Cash Equivalents

    n/a
    		 5.72M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -444.23M

    Total Assets

    n/a
    		 23.26M

    Working Capital

    n/a
    		 10.85M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -17.49M and capital expenditures -100K, giving a free cash flow of -17.59M.

    Operating Cash Flow

    n/a
    		 -17.49M

    Capital Expenditures

    n/a
    		 -100K

    Free Cash Flow

    n/a
    		 -17.59M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -2594.32% and -1580.18%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -2594.32%

    Pretax Margin

    n/a
    		 -1580.18%

    Profit Margin

    n/a
    		 -1580.18%

    EBITDA Margin

    n/a
    		 -2594.32%

    EBIT Margin

    n/a
    		 -2594.32%

    FCF Margin

    n/a
    		 -2702.3%

    Dividends & Yields

    ACRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -0.1%

    FCF Yield

    n/a
    		 -0.17%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ACRX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 26, 2022. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Oct 26, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -26.17

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist